Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Samuel C. Wagner"'
Autor:
Thomas E. Ichim, Francisco Silva, Santosh Kesari, Amit N. Patel, Samuel C. Wagner, Wei-Ping Min, Vladimir Bogin
Publikováno v:
Oncotarget
// Samuel C. Wagner 1, * , Thomas E. Ichim 1, * , Vladimir Bogin 1 , Wei-Ping Min 2 , Francisco Silva 3 , Amit N. Patel 3 , Santosh Kesari 4 1 Batu Biologics, Inc. San Diego, CA, USA 2 Department of Immunology, University of Western Ontario, London,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ecc3423b0460859636a990dd967b47f
https://doi.org/10.18632/oncotarget.15563
https://doi.org/10.18632/oncotarget.15563
Autor:
Andy J. Kim, James Koropatnick, Samuel C. Wagner, Constantin A Dasanu, Boris Markosian, Francesco M. Marincola, Neil H. Riordan, Doru T Alexandrescu, Naseem Ajili, Brandon R. Dolan, Boris Minev
Publikováno v:
Journal of Translational Medicine
Interleukin-2 (IL-2) therapy has been demonstrated to induce responses in 10-20% of advanced melanoma and renal cell carcinoma patients, which translates into durable remissions in up to half of the responsers. Unfortunately the use of IL-2 has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6567a176bde931ab6281a5395cc53f6a
https://pubmed.ncbi.nlm.nih.gov/24884532
https://pubmed.ncbi.nlm.nih.gov/24884532
Autor:
Jesus A. Perez, Juan J. Plata-Munoz, Hong Ma, Thomas E. Ichim, Amit N. Patel, Javier Lopez, Santosh Kesari, F. Silva, Julia S. Szymanski, Samuel C. Wagner, Neil H. Riordan
Publikováno v:
Journal of Translational Medicine
The mechanisms underlying discrimination between "self" and "non-self", a central immunological principle, require careful consideration in immune oncology therapeutics where eliciting anti-cancer immunity must be weighed against the risk of autoimmu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edb34daa4ac04f9c8f72730a544200d0
Autor:
Shuang Li, Hong Ma, Amit N. Patel, Santosh Kesari, Julia S. Szymanski, Thomas E. Ichim, Samuel C. Wagner, Wei-Ping Min, Yuliya V. Yurova
Publikováno v:
Journal of Translational Medicine
Background While the concept of angiogenesis blockade as a therapeutic intervention for cancer has been repeatedly demonstrated, the full promise of this approach has yet to be realized. Specifically, drugs such as VEGF-blocking antibodies or kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d8a5d412cd0e5893b48f61f655869a3